Fu­ji­film Diosynth dumps an­oth­er $454M in­to its sup­ply chain, this time at a fa­cil­i­ty in the UK

Fu­ji­film Diosynth Biotech­nolo­gies is in the mid­dle of a mon­u­men­tal point in the com­pa­ny’s 10-year his­to­ry, and the CD­MO is about to grow even more, as it sets out to be the “beat­ing heart” of the UK’s North East Life Sci­ences ecosys­tem.

A site in Billing­ham, Tee­side, UK will re­ceive a $453.72 mil­lion in­vest­ment pack­age from the man­u­fac­tur­er to dou­ble the ex­ist­ing foot­print and cre­ate the largest mul­ti-modal bio­phar­ma­ceu­ti­cal man­u­fac­tur­ing site in the UK, bring­ing an­oth­er 350 jobs to the re­gion by late 2023.

Endpoints News

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters